SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-185432
Filing Date
2021-06-08
Accepted
2021-06-08 16:18:06
Documents
15
Period of Report
2021-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d186085d8k.htm   iXBRL 8-K 40737
2 EX-4.1 d186085dex41.htm EX-4.1 998417
3 EX-99.1 d186085dex991.htm EX-99.1 18061
7 GRAPHIC g186085g001.jpg GRAPHIC 4406
  Complete submission text file 0001193125-21-185432.txt   1418574

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bhc-20210607.xsd EX-101.SCH 2732
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20210607_lab.xml EX-101.LAB 19578
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20210607_pre.xml EX-101.PRE 12275
8 EXTRACTED XBRL INSTANCE DOCUMENT d186085d8k_htm.xml XML 3961
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 211002372
SIC: 2834 Pharmaceutical Preparations